Nanoradox – HNCs - Vision Oncology

Nanoradox is a Class III medical device that, in in-vivo studies, shows an inhibition of the growth of the tumor mass by over 50%.

Nanoradox is a non-invasive, non-toxic hyperemic treatment that can support pharmacological therapies. It is essential for extending patients’ lives and significantly increasing their quality of life during and after the illness.

First indication: head and neck cancers*

7th

MOST COMMON CANCER GLOBALLY

932.000

NEW CASES
EVERY YEAR

467.000

DEATHS
EVERY YEAR

< 50 %

5 YEARS
SURVIVAL RATE

* Source: Sung H, Ferlay J, Siegel R L et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians 2021; 71: 209-249.

Head and neck cancers

Cancers that are known collectively as head and neck cancers (HNCs) usually (90% of cases) begin in the squamous cell that line the mucosal surfaces of the head and neck. These cancers are referred to as squamous cell carcinomas of the head and neck.

List of malignant neoplasms

Main siteICD-10 code
Malignant neoplasms of lipC00
Malignant neoplasm of base of tongueC01
Malignant neoplasm of other and unspecified part of tongueC02
Malignant neoplasm of gumC03
Malignant neoplasm of floor of mouthC04
Malignant neoplasm of palateC05
Malignant neoplasm of other and unspecified parts of mouthC06
Malignant neoplasm of parotid glandC07
Malignant neoplasm of other and unspecified major salivary glandsC08
Malignant neoplasm of tonsilC09
Malignant neoplasm of oropharynxC10
Malignant neoplasm of nasopharynxC11
Malignant neoplasm of piriform sinusC12
Malignant neoplasm of hypopharynxC13
Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynxC14
Malignant neoplasm of nasal cavity and middle earC30
Malignant neoplasm of accessory sinusesC31
Malignant neoplasm of larynxC32
Malignant neoplasm of other and ill-defined sitesC76

How Nanoradox works

* This image is just a render and can not correspond to the actual machine

Hyperthermia destroys the tumor mass

Each session consists of three treatments over three consecutive days.

Nanoradox - Vision Oncology

Our roadmap